Janus Henderson Group
CAMP icon

Janus Henderson Group’s CAMP4 Therapeutics CAMP Stock Holding History

Janus Henderson Group’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.9M Hold
6,307,636
– – 0.01% 535
2025
Q4 		$38.8M Buy
6,307,636
+1,666,666
+36% +$7.09M 0.02% 463
2025
Q3 		$13.9M Buy
+4,640,970
New +$8.6M 0.01% 684

Other funds holding CAMP

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Janus Henderson Group's CAMP Position: Q1 2026 in Review

Janus Henderson Group held its CAMP4 Therapeutics (CAMP) position steady in Q1 2026 at 6,307,636 shares worth $27.9M. The position accounts for 0.01% of the portfolio, ranked #535.

Janus Henderson Group first reported a position in CAMP in Q3 2025 and has held it in 3 quarters since. The position peaked at $38.8M in Q4 2025. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • Janus Henderson Group held 6,307,636 shares of CAMP4 Therapeutics worth $27.9M as of Q1 2026.
  • Janus Henderson Group left its CAMP4 Therapeutics share count unchanged in Q1 2026.
  • CAMP4 Therapeutics made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #535 holding.
  • Janus Henderson Group first reported a position in CAMP4 Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Janus Henderson Group's CAMP4 Therapeutics position peaked at $38.8M in Q4 2025.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.